Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Transgene and Jennerex enter into exclusive partnership for JX-594

Sep. 9, 2010

Patient enrollment complete in Antisoma's phase III trial of AS-1413

Sep. 9, 2010

Onyx and Ono sign Japanese agreements for oncology drugs carfilzomib and ONX-0912

Sep. 8, 2010

FDA clears IND for Tekmira's TKM-PLK1

Sep. 8, 2010

CytRx begins phase II bafetinib trial in advanced prostate cancer

Sep. 8, 2010

Italian scientists synthesize new HDAC inhibitor

Sep. 8, 2010

OriBase Pharma describes new tyrosine protein kinase inhibitors

Sep. 8, 2010

Scancell reports encouraging data on DNA vaccine in animal model of melanoma

Sep. 7, 2010

Eisai launches bendamustine in Singapore for non-Hodgkin's lymphoma and CLL

Sep. 7, 2010

AstraZeneca describes new androgen receptor ligands

Sep. 7, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...